Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (16028)	9/3/2002 8:51:04 PM
From: Robert S.	Read Replies (1) \| Respond to of 17367

George............. Meningococcemia, Trauma, Allergan, Baxter, Crohn's, Joslin and countless research projects on BPI. Have the actions produced the results we all want apparently not BPI was discovered in 1978. It is now 2002. Wake up and smell the coffee.

To: aknahow who wrote (16028)	9/3/2002 10:28:48 PM
From: Robert K.	Read Replies (1) \| Respond to of 17367

George, let me state it another way for you. Xoma keeps blending bpi further and further into the "backround". Look at their website. First it was mostly about bpi. Then it was about bpi & hu1124, then its mostly about hu-1124. They dropped mycoprex despite the fact it kick fungal butt. One has to wonder if xoma themselves are commited to bpi (let alone baxter). I dont wonder anymore, either i see results or I assume thay are not committed. I hope to see results, but I aint in any way getting any hopes up at this juncture. Whatever happens my few shares will do me just fine, I can accelerate my percentage on quick notice and I would be just as happy to see it run up fast on me.